ABUS logo

Arbutus Biopharma Corporation (ABUS) Operating profit

annual operating profit:

-$69.97M+$8.06M(+10.33%)
December 31, 2024

Summary

  • As of today (August 20, 2025), ABUS annual operating income is -$69.97 million, with the most recent change of +$8.06 million (+10.33%) on December 31, 2024.
  • During the last 3 years, ABUS annual operating profit has risen by +$1.68 million (+2.34%).
  • ABUS annual operating profit is now -1620.98% below its all-time high of $4.60 million, reached on December 31, 2006.

Performance

ABUS Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

quarterly operating profit:

$1.91M+$14.94M(+114.68%)
June 30, 2025

Summary

  • As of today (August 20, 2025), ABUS quarterly operating income is $1.91 million, with the most recent change of +$14.94 million (+114.68%) on June 30, 2025.
  • Over the past year, ABUS quarterly operating profit has increased by +$23.29 million (+108.95%).
  • ABUS quarterly operating profit is now -75.29% below its all-time high of $7.74 million, reached on March 1, 2005.

Performance

ABUS quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

TTM operating profit:

-$40.53M+$23.29M(+36.49%)
June 30, 2025

Summary

  • As of today (August 20, 2025), ABUS TTM operating income is -$40.53 million, with the most recent change of +$23.29 million (+36.49%) on June 30, 2025.
  • Over the past year, ABUS TTM operating profit has increased by +$41.90 million (+50.83%).
  • ABUS TTM operating profit is now -620.61% below its all-time high of $7.79 million, reached on March 1, 2007.

Performance

ABUS TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ABUS Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.3%+109.0%+50.8%
3 y3 years+2.3%+113.8%+35.5%
5 y5 years+1.9%+114.7%+29.6%

ABUS Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.7%+10.3%at high+109.0%at high+50.8%
5 y5-year-22.2%+10.3%at high+109.0%at high+50.8%
alltimeall time-1621.0%+10.3%-75.3%+108.3%-620.6%+50.8%

ABUS Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.91M(-114.7%)
-$40.53M(-36.5%)
Mar 2025
-
-$13.03M(+9.0%)
-$63.82M(-8.8%)
Dec 2024
-$69.97M(-10.3%)
-$11.95M(-31.6%)
-$69.97M(-10.9%)
Sep 2024
-
-$17.47M(-18.3%)
-$78.55M(-4.7%)
Jun 2024
-
-$21.37M(+11.4%)
-$82.43M(+2.9%)
Mar 2024
-
-$19.18M(-6.5%)
-$80.08M(+2.6%)
Dec 2023
-$78.03M(+23.4%)
-$20.52M(-3.9%)
-$78.03M(-0.6%)
Sep 2023
-
-$21.35M(+12.3%)
-$78.47M(+5.0%)
Jun 2023
-
-$19.02M(+11.0%)
-$74.71M(+7.4%)
Mar 2023
-
-$17.14M(-18.2%)
-$69.59M(+10.1%)
Dec 2022
-$63.22M(-11.8%)
-$20.95M(+19.1%)
-$63.22M(+0.6%)
Sep 2022
-
-$17.60M(+26.6%)
-$62.87M(+0.1%)
Jun 2022
-
-$13.90M(+29.0%)
-$62.83M(-6.1%)
Mar 2022
-
-$10.77M(-47.7%)
-$66.88M(-6.7%)
Dec 2021
-$71.65M(+25.1%)
-$20.60M(+17.4%)
-$71.65M(+6.6%)
Sep 2021
-
-$17.55M(-2.2%)
-$67.22M(+3.8%)
Jun 2021
-
-$17.95M(+15.4%)
-$64.77M(+8.2%)
Mar 2021
-
-$15.55M(-3.9%)
-$59.84M(+4.5%)
Dec 2020
-$57.27M(-19.7%)
-$16.18M(+7.1%)
-$57.27M(+5.5%)
Sep 2020
-
-$15.10M(+16.0%)
-$54.28M(-5.8%)
Jun 2020
-
-$13.02M(+0.3%)
-$57.61M(-11.9%)
Mar 2020
-
-$12.98M(-1.6%)
-$65.37M(-8.4%)
Dec 2019
-$71.34M(+1.6%)
-$13.18M(-28.4%)
-$71.34M(-3.6%)
Sep 2019
-
-$18.43M(-11.3%)
-$73.98M(+0.4%)
Jun 2019
-
-$20.78M(+9.6%)
-$73.66M(+1.8%)
Mar 2019
-
-$18.95M(+19.8%)
-$72.34M(+3.1%)
Dec 2018
-$70.19M(+0.1%)
-$15.82M(-12.7%)
-$70.17M(-4.9%)
Sep 2018
-
-$18.11M(-7.0%)
-$73.81M(+7.6%)
Jun 2018
-
-$19.46M(+16.0%)
-$68.60M(-0.0%)
Mar 2018
-
-$16.78M(-13.7%)
-$68.62M(-2.2%)
Dec 2017
-$70.13M(+2.7%)
-$19.45M(+50.8%)
-$70.13M(+0.0%)
Sep 2017
-
-$12.90M(-33.8%)
-$70.10M(-4.2%)
Jun 2017
-
-$19.48M(+6.5%)
-$73.17M(-4.6%)
Mar 2017
-
-$18.30M(-5.8%)
-$76.71M(+4.2%)
Dec 2016
-$68.29M(+84.8%)
-$19.42M(+21.5%)
-$73.59M(+24.3%)
Sep 2016
-
-$15.97M(-30.6%)
-$59.22M(+2.6%)
Jun 2016
-
-$23.02M(+51.7%)
-$57.69M(+29.3%)
Mar 2016
-
-$15.18M(+201.1%)
-$44.63M(+20.7%)
Dec 2015
-$36.96M(+12.1%)
-$5.04M(-65.1%)
-$36.96M(-13.4%)
Sep 2015
-
-$14.45M(+45.1%)
-$42.66M(+21.7%)
Jun 2015
-
-$9.96M(+32.6%)
-$35.06M(+1.6%)
Mar 2015
-
-$7.51M(-30.1%)
-$34.52M(+4.7%)
Dec 2014
-$32.97M(+171.3%)
-$10.75M(+57.0%)
-$32.97M(+33.7%)
Sep 2014
-
-$6.84M(-27.4%)
-$24.66M(+15.0%)
Jun 2014
-
-$9.42M(+58.2%)
-$21.44M(+41.9%)
Mar 2014
-
-$5.96M(+144.5%)
-$15.11M(+23.8%)
Dec 2013
-$12.15M(-6.0%)
-$2.44M(-32.7%)
-$12.20M(-22.2%)
Sep 2013
-
-$3.62M(+17.1%)
-$15.69M(+13.3%)
Jun 2013
-
-$3.09M(+1.1%)
-$13.85M(+4.0%)
Mar 2013
-
-$3.06M(-48.4%)
-$13.32M(+3.3%)
Dec 2012
-$12.93M
-$5.92M(+232.7%)
-$12.89M(+42.6%)
Sep 2012
-
-$1.78M(-30.3%)
-$9.04M(+0.7%)
Jun 2012
-
-$2.56M(-2.9%)
-$8.98M(-11.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$2.63M(+26.8%)
-$10.16M(-4.6%)
Dec 2011
-$10.62M(+65.7%)
-$2.08M(+21.0%)
-$10.65M(-31.4%)
Sep 2011
-
-$1.72M(-54.1%)
-$15.54M(+44.3%)
Jun 2011
-
-$3.74M(+19.9%)
-$10.77M(-2.8%)
Mar 2011
-
-$3.12M(-55.2%)
-$11.08M(-9.7%)
Dec 2010
-$6.41M(-23.0%)
-$6.96M(-327.8%)
-$12.26M(+60.5%)
Sep 2010
-
$3.06M(-175.4%)
-$7.64M(-41.5%)
Jun 2010
-
-$4.05M(-5.9%)
-$13.05M(+19.6%)
Mar 2010
-
-$4.30M(+84.0%)
-$10.91M(+30.2%)
Dec 2009
-$8.32M(-12.5%)
-$2.34M(-0.8%)
-$8.38M(+16.7%)
Sep 2009
-
-$2.36M(+23.4%)
-$7.18M(-4.5%)
Jun 2009
-
-$1.91M(+7.9%)
-$7.52M(-30.2%)
Mar 2009
-
-$1.77M(+54.9%)
-$10.77M(+9.2%)
Dec 2008
-$9.51M(-490.7%)
-$1.14M(-57.6%)
-$9.86M(+14.2%)
Sep 2008
-
-$2.70M(-47.8%)
-$8.64M(+97.3%)
Jun 2008
-
-$5.16M(+498.7%)
-$4.38M(-556.0%)
Mar 2008
-
-$862.40K(-1178.0%)
$960.30K(-60.4%)
Dec 2007
$2.43M(-47.1%)
$80.00K(-94.9%)
$2.42M(+4.0%)
Sep 2007
-
$1.57M(+789.6%)
$2.33M(-50.3%)
Jun 2007
-
$176.10K(-70.7%)
$4.68M(-39.8%)
Mar 2007
-
$600.30K(-4450.0%)
$7.79M(+64.7%)
Dec 2006
$4.60M(-490.8%)
-
-
Dec 2006
-
-$13.80K(-100.4%)
$4.73M(+177.0%)
Sep 2006
-
$3.92M(+19.6%)
$1.71M(-136.5%)
Jun 2006
-
$3.28M(-233.4%)
-$4.67M(-59.3%)
Mar 2006
-
-$2.46M(-19.0%)
-$11.49M(+790.4%)
Dec 2005
-$1.18M(-94.6%)
-
-
Dec 2005
-
-$3.03M(+23.5%)
-$1.29M(-81.2%)
Sep 2005
-
-$2.46M(-30.6%)
-$6.86M(-25.7%)
Jun 2005
-
-$3.54M(-145.7%)
-$9.23M(-8.8%)
Mar 2005
-
$7.74M(-190.0%)
-$10.13M(-53.7%)
Dec 2004
-$21.88M(-31.8%)
-
-
Dec 2004
-
-$8.61M(+78.2%)
-$21.86M(-4.5%)
Sep 2004
-
-$4.83M(+8.9%)
-$22.89M(-10.3%)
Jun 2004
-
-$4.44M(+11.4%)
-$25.52M(+21.0%)
Mar 2004
-
-$3.98M(-58.7%)
-$21.09M(+23.3%)
Dec 2003
-$32.08M(+15.5%)
-
-
Dec 2003
-
-$9.64M(+29.2%)
-$17.10M(+1.4%)
Sep 2003
-
-$7.46M(-20.6%)
-$16.86M(-39.3%)
Dec 2002
-$27.79M(+64.7%)
-
-
Dec 2002
-
-$9.40M(+20.6%)
-$27.79M(+12.3%)
Sep 2002
-
-$7.80M(+56.2%)
-$24.75M(+18.4%)
Jun 2002
-
-$4.99M(-10.9%)
-$20.89M(+4.5%)
Mar 2002
-
-$5.60M(-11.9%)
-$20.00M(+16.7%)
Dec 2001
-$16.87M(+53.0%)
-
-
Dec 2001
-
-$6.36M(+61.3%)
-$17.13M(+59.0%)
Sep 2001
-
-$3.94M(-3.9%)
-$10.78M(+57.7%)
Jun 2001
-
-$4.10M(+49.9%)
-$6.83M(+149.9%)
Mar 2001
-
-$2.73M
-$2.73M
Dec 2000
-$11.03M(+28.5%)
-
-
Dec 1999
-$8.58M(-12.9%)
-
-
Dec 1998
-$9.85M(+30.7%)
-
-
Dec 1997
-$7.54M
-
-

FAQ

  • What is Arbutus Biopharma Corporation annual operating income?
  • What is the all time high annual operating profit for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation annual operating profit year-on-year change?
  • What is Arbutus Biopharma Corporation quarterly operating income?
  • What is the all time high quarterly operating profit for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation quarterly operating profit year-on-year change?
  • What is Arbutus Biopharma Corporation TTM operating income?
  • What is the all time high TTM operating profit for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation TTM operating profit year-on-year change?

What is Arbutus Biopharma Corporation annual operating income?

The current annual operating profit of ABUS is -$69.97M

What is the all time high annual operating profit for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high annual operating income is $4.60M

What is Arbutus Biopharma Corporation annual operating profit year-on-year change?

Over the past year, ABUS annual operating income has changed by +$8.06M (+10.33%)

What is Arbutus Biopharma Corporation quarterly operating income?

The current quarterly operating profit of ABUS is $1.91M

What is the all time high quarterly operating profit for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high quarterly operating income is $7.74M

What is Arbutus Biopharma Corporation quarterly operating profit year-on-year change?

Over the past year, ABUS quarterly operating income has changed by +$23.29M (+108.95%)

What is Arbutus Biopharma Corporation TTM operating income?

The current TTM operating profit of ABUS is -$40.53M

What is the all time high TTM operating profit for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high TTM operating income is $7.79M

What is Arbutus Biopharma Corporation TTM operating profit year-on-year change?

Over the past year, ABUS TTM operating income has changed by +$41.90M (+50.83%)
On this page